May 23, 2023, Avidity Biosciences Inc. (NASDAQ: RNA) trading session started at the price of $12.17, that was -3.15% drop from the session before. During the day, the shares moved up to $12.53 and dropped to $11.68 before settling in for the closing price of $12.08. A 52-week range for RNA has been $9.83 – $25.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -17.10%. With a float of $50.87 million, this company’s outstanding shares have now reached $70.43 million.
Let’s look at the performance matrix of the company that is accounted for 186 employees.
Avidity Biosciences Inc. (RNA) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Avidity Biosciences Inc. stocks. The insider ownership of Avidity Biosciences Inc. is 5.17%, while institutional ownership is 99.00%. The most recent insider transaction that took place on Mar 15, was worth 2,201. In this transaction Director of this company sold 100 shares at a rate of $22.01, taking the stock ownership to the 19,330 shares. Before that another transaction happened on Feb 14, when Company’s Chief Scientific Officer sold 10,000 for $23.66, making the entire transaction worth $236,567. This insider now owns 19,330 shares in total.
Avidity Biosciences Inc. (RNA) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 3/30/2023, it has been observed that the corporation posted -$0.74 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.85) by $0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -17.10% per share during the next fiscal year.
Avidity Biosciences Inc. (NASDAQ: RNA) Trading Performance Indicators
You can see what Avidity Biosciences Inc. (RNA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 12.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 84.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.36, a number that is poised to hit -0.80 in the next quarter and is forecasted to reach -3.40 in one year’s time.
Technical Analysis of Avidity Biosciences Inc. (RNA)
Avidity Biosciences Inc. (NASDAQ: RNA) saw its 5-day average volume 1.2 million, a positive change from its year-to-date volume of 1.16 million. As of the previous 9 days, the stock’s Stochastic %D was 60.54%. Additionally, its Average True Range was 0.98.
During the past 100 days, Avidity Biosciences Inc.’s (RNA) raw stochastic average was set at 8.59%, which indicates a significant decrease from 61.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.98% in the past 14 days, which was lower than the 81.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.13, while its 200-day Moving Average is $17.89. Nevertheless, the first resistance level for the watch stands at $12.26 in the near term. At $12.82, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.11. If the price goes on to break the first support level at $11.41, it is likely to go to the next support level at $11.12. Assuming the price breaks the second support level, the third support level stands at $10.56.
Avidity Biosciences Inc. (NASDAQ: RNA) Key Stats
There are 70,819K outstanding shares of the company, which has a market capitalization of 818.65 million. As of now, sales total 9,220 K while income totals -174,000 K. Its latest quarter income was 2,230 K while its last quarter net income were -52,390 K.
